Richard Curry

Richard Curry

Company: Bexion

Job title: Medical Affairs Advisor


Leveraging the Lysosome to Treat Glioblastoma 2:40 pm

BXQ-350 – a unique, first in class, lysosomal protein (in lipid nanovesicle) involved in cellular homeostasis Phase 1 clinical trial findings of extraordinary safety and tolerability with monotherapy effect Planned clinical trials in newly diagnosed GBM – combination therapy with radiation and temozolomideRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.